Zimmer Biomet Holdings Inc
Research Zimmer Biomet Holdings Inc (ZBH) on Bullrun: valuation model: 6.0% undervalued, market cap USD 16.99B, P/E 21.7, dividend yield 1.0%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerZBH
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Valuation signal6.0% undervalued
- Market capUSD 16.99B
- P/E21.7
- Dividend yield1.0%
- Financial periodQ2 2026
- RevenueUSD 2.18B
- Net incomeUSD 198.30M
- Free cash flowUSD 331.40M
- Gross margin70.8%
Valuation Snapshot
Bullrun's latest valuation model marks Zimmer Biomet Holdings Inc as 6.0% undervalued; latest market cap is USD 16.99B; P/E is 21.7; dividend yield is 1.0%.
Peer valuation comparison
Latest P/E is 21.69x versus a Healthcare sector median of 24.61x (11.8% below).
Latest dividend yield is 1.04% versus a Healthcare sector median of 1.84% (43.5% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 8.23B | USD 705.10M | USD 1.47B | 69.7% | 3.55 | USD 591.90M | USD 7.52B | USD 12.70B |
| FY2024 | USD 7.68B | USD 903.80M | USD 1.30B | 71.5% | 4.43 | USD 525.50M | USD 6.20B | USD 12.47B |
| FY2023 | USD 7.39B | USD 1.02B | USD 1.29B | 71.8% | 4.88 | USD 415.80M | USD 5.77B | USD 12.48B |
| FY2022 | USD 6.94B | USD 231.40M | USD 1.17B | 70.9% | 1.1 | USD 375.70M | USD 5.70B | USD 12.02B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 16.99B | 21.7 | 1.1% | 0.96 |
| 2025 | 2025-12-31 | USD 17.58B | 25.3 | 1.1% | 0.96 |
| 2024 | 2024-12-31 | USD 21.03B | 23.8 | 0.9% | 0.96 |
| 2023 | 2023-12-29 | USD 25.43B | 53.8 | 0.8% | 0.96 |
| 2022 | 2022-12-30 | USD 26.76B | 96.6 | 0.8% | 0.96 |
| 2021 | 2021-12-31 | USD 25.78B | 64.6 | 0.7% | 0.92 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.96 USD, yield 1.0%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.96 USD |
| FY2024 | 0.96 USD |
| FY2023 | 0.96 USD |
| FY2022 | 0.96 USD |
About Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder;
ETFs that hold Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings Inc is one of the ten largest holdings of 3 ETFs that investors in Europe can buy, most traded first:
| ETF | Weight | TER |
|---|---|---|
| VanEck Morningstar US ESG Wide Moat UCITS ETF | 2.56% | 0.49% |
| VanEck Morningstar Global Wide Moat UCITS ETF A USD | 1.96% | 0.52% |
| VanEck Medical Robotics and Bionic Engineering UCITS ETF | 3.98% | 0.55% |
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Zimmer Biomet Holdings Inc overvalued or undervalued?
Bullrun's valuation model currently marks Zimmer Biomet Holdings Inc as 6.0% undervalued.
What is Zimmer Biomet Holdings Inc's market cap?
Zimmer Biomet Holdings Inc's market capitalization is USD 16.99B.
What is Zimmer Biomet Holdings Inc's P/E ratio?
Zimmer Biomet Holdings Inc's price-to-earnings (P/E) ratio is 21.7.
Does Zimmer Biomet Holdings Inc pay a dividend?
Zimmer Biomet Holdings Inc has a dividend yield of 1.0%.
What does Zimmer Biomet Holdings Inc do?
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T.